Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04931368
Title OptiMATe: De-escalated Induction Treatment in Primary CNS Lymphoma (OptiMATe)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Klinikum Stuttgart
Indications

central nervous system lymphoma

Therapies

Cytarabine + Methotrexate + Rituximab + Thiotepa

Age Groups: adult | senior
Covered Countries DEU


No variant requirements are available.